Literature DB >> 17486320

Enforcement of the ban on aristolochic acids in Chinese traditional herbal preparations on the Dutch market.

Martijn J Martena1, Jacqueline C A van der Wielen, Leo F J van de Laak, Erik J M Konings, Henk N de Groot, Ivonne M C M Rietjens.   

Abstract

In traditional Chinese medicine several Aristolochia species are used. Aristolochia spp. contain a mixture of aristolochic acids (AAs), mainly AA I and AA II which are nephrotoxicants and carcinogens. After AA-related nephropathy (AAN) and urothelial cancer were described in female patients in Belgium following intake of AA-contaminated herbal preparations, herbs with AAs were prohibited worldwide. Confusing nomenclature can cause AA contamination of certain Chinese traditional herbal preparations (THPs). Here we report the results of investigations by the Dutch Food and Consumer Product Safety Authority (VWA) into the presence of AAs in THPs sampled on the Dutch market using a liquid-chromatography--mass spectrometry method. Between 2002 and 2006 we sampled 190 Chinese THPs using recent information on Chinese THPs potentially containing AAs. AA I was found in 25 samples up to a concentration of 1,676 mg/kg. AA II was also found in 13 of these samples up to 444 mg/kg. All 25 positive samples including Mu Tong, Fang Ji, Tian Xian Teng and Xi Xin were part of a group of 68 THPs identified as possibly containing AAs. In a worst-case scenario, use of a sample of Mu Tong with the highest AA content over a 7-day period would result in the same intake levels of AAs which significantly raised the cancer risk in the Belgian AAN cases. Our results show that contaminated THPs still can be found on the market following worldwide publicity. Therefore, it can be concluded that testing of possibly AA-contaminated THPs is still essential.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17486320     DOI: 10.1007/s00216-007-1310-3

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  16 in total

1.  Potential risks associated with the use of herbal anti-obesity products.

Authors:  Thomas Y K Chan
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

2.  Aristolochic acid-associated urothelial cancer in Taiwan.

Authors:  Chung-Hsin Chen; Kathleen G Dickman; Masaaki Moriya; Jiri Zavadil; Viktoriya S Sidorenko; Karen L Edwards; Dmitri V Gnatenko; Lin Wu; Robert J Turesky; Xue-Ru Wu; Yeong-Shiau Pu; Arthur P Grollman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-09       Impact factor: 11.205

Review 3.  Aristolochic acid-associated cancers: a public health risk in need of global action.

Authors:  Samrat Das; Shefali Thakur; Michael Korenjak; Viktoriya S Sidorenko; Felicia Fei-Lei Chung; Jiri Zavadil
Journal:  Nat Rev Cancer       Date:  2022-07-19       Impact factor: 69.800

Review 4.  Complications of traditional Chinese/herbal medicines (TCM)--a guide for perplexed oncologists and other cancer caregivers.

Authors:  Joanne Chiu; Thomas Yau; Richard J Epstein
Journal:  Support Care Cancer       Date:  2008-11-14       Impact factor: 3.603

5.  An integrated system for identifying the hidden assassins in traditional medicines containing aristolochic acids.

Authors:  Lan Wu; Wei Sun; Bo Wang; Haiyu Zhao; Yaoli Li; Shaoqing Cai; Li Xiang; Yingjie Zhu; Hui Yao; Jingyuan Song; Yung-Chi Cheng; Shilin Chen
Journal:  Sci Rep       Date:  2015-08-13       Impact factor: 4.379

Review 6.  Chinese herbs containing aristolochic acid associated with renal failure and urothelial carcinoma: a review from epidemiologic observations to causal inference.

Authors:  Hsiao-Yu Yang; Pau-Chung Chen; Jung-Der Wang
Journal:  Biomed Res Int       Date:  2014-08-27       Impact factor: 3.411

7.  Identification and determination of the major constituents in traditional Chinese medicine Longdan Xiegan Pill by HPLC-DAD-ESI-MS.

Authors:  Hui Liu; Juan Su; Xu Liang; Xi Zhang; Ya-Jun He; Hai-Qiang Huang; Ji Ye; Wei-Dong Zhang
Journal:  J Pharm Anal       Date:  2012-01-30

Review 8.  Integration of botanicals in contemporary medicine: road blocks, checkpoints and go-ahead signals.

Authors:  Neha Arora Chugh; Shreya Bali; Ashwani Koul
Journal:  Integr Med Res       Date:  2018-03-28

9.  Metabolomic analysis of complex chinese remedies: examples of induced nephrotoxicity in the mouse from a series of remedies containing aristolochic Acid.

Authors:  Dong-Ming Tsai; Jaw-Jou Kang; Shoei-Sheng Lee; San-Yuan Wang; I-Lin Tsai; Guan-Yuan Chen; Hsiao-Wei Liao; Li Wei-Chu; Ching-Hua Kuo; Y Jane Tseng
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-31       Impact factor: 2.629

10.  Toward clinical understanding of aristolochic acid upper-tract urothelial carcinoma.

Authors:  Arnoud Boot; Nanhai Jiang; Steven G Rozen
Journal:  Theranostics       Date:  2020-04-21       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.